# Eurofins PROXY Laboratories B.V. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/eurofins-proxy-laboratories-bv/2efa7b51-ca37-4d11-aa86-bb3a7d987ca7

> Inspection records and compliance data for Eurofins PROXY Laboratories B.V. in Leiden, None. Access full analysis and detailed observations.

---

## Details

- Name: Eurofins PROXY Laboratories B.V.
- FEI Number: 3004594563
- City: Leiden
- State: None
- Country Name: Netherlands
- Address Line 1: Darwinweg 24
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Eurofins PROXY Laboratories B.V. - 2025-09-19](https://www.globalkeysolutions.net/records/483/eurofins-proxy-laboratories-bv/4af7ca66-83d1-41ef-8b0f-d8d7aa19ed79) — source: FDA, date: September 19, 2025
- [FDA Inspection 1282304 - Eurofins PROXY Laboratories B.V. - 2025-09-19](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-proxy-laboratories-bv/d3a4d5e2-2e84-408b-9421-569f11751a8c) — source: FDA, date: September 19, 2025
- [FDA Inspection 1282304 - Eurofins PROXY Laboratories B.V. - 2025-09-19](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-proxy-laboratories-bv/f1eb44ef-9892-4fe4-9d23-e68381a1b417) — source: FDA, date: September 19, 2025
- [FDA Inspection 1282304 - Eurofins PROXY Laboratories B.V. - 2025-09-19](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-proxy-laboratories-bv/b9470d13-8e8a-44f0-b78b-4102ed80ebd9) — source: FDA, date: September 19, 2025
- [FDA Inspection 1272171 - Eurofins PROXY Laboratories B.V. - 2022-07-01](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-proxy-laboratories-bv/4fb38a28-244b-46d9-a129-76de244652b3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 1, 2022
- [FDA Inspection 1124234 - Eurofins PROXY Laboratories B.V. - 2019-08-21](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-proxy-laboratories-bv/1ef42cde-d0b9-4b78-92c5-baef5d3d79ac) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 21, 2019
- [483 - Eurofins PROXY Laboratories B.V. - 2017-09-07](https://www.globalkeysolutions.net/records/483/eurofins-proxy-laboratories-bv/d7fc0f09-cfaa-4ba4-988f-bea088e0177f) — source: FDA, date: September 7, 2017
- [FDA Inspection 1028845 - Eurofins PROXY Laboratories B.V. - 2017-09-07](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-proxy-laboratories-bv/3ae54340-2ba7-474f-81da-56b1b9577a76) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 7, 2017
- [EIR - Eurofins PROXY Laboratories B.V. - 2016-09-16](https://www.globalkeysolutions.net/records/eir/eurofins-proxy-laboratories-bv/b7adc238-01e4-41b6-9bd3-5e8d0bd7a7a9) — source: FDA, date: September 16, 2016
- [483 - Eurofins PROXY Laboratories B.V. - 2014-11-06](https://www.globalkeysolutions.net/records/483/eurofins-proxy-laboratories-bv/56905317-dd87-4565-8f8f-965fdf229b8b) — source: FDA, date: November 6, 2014
- [FDA Inspection 904889 - Eurofins PROXY Laboratories B.V. - 2014-11-06](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-proxy-laboratories-bv/c79daf6c-25de-471a-92a9-afa91b6862e2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 6, 2014
- [FDA Inspection 750139 - Eurofins PROXY Laboratories B.V. - 2011-09-15](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-proxy-laboratories-bv/bc6c6bcf-b904-41bb-b5f1-8ea2083ce55a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 15, 2011

## Related Companies

- [Haematologic Technologies, LLC dba Prolytix](https://www.globalkeysolutions.net/companies/haematologic-technologies-llc-dba-prolytix/03297ca5-f207-401a-8202-1b343903beed)
- [Microbiological Testing & Consulting LLC](https://www.globalkeysolutions.net/companies/microbiological-testing-consulting-llc/87a00b18-b929-4bbd-af7a-948bc27294dc)
- [PPD Development, L.P.](https://www.globalkeysolutions.net/companies/ppd-development-lp/c8b3d3b0-5856-4714-bc30-21345649d782)
- [Ultragenyx Pharmaceutical Inc.](https://www.globalkeysolutions.net/companies/ultragenyx-pharmaceutical-inc/52e0a912-e566-4a1d-89b4-822a2feaf1d0)
- [Accuon Labs, Inc](https://www.globalkeysolutions.net/companies/accuon-labs-inc/05b05575-7dfc-4ed4-b00a-d21260d0438d)
- [Sarepta Therapeutics Inc](https://www.globalkeysolutions.net/companies/sarepta-therapeutics-inc/5a8d2168-ec04-4530-a81f-00bab06c4a44)
- [CHARLES RIVER LABORATORIES](https://www.globalkeysolutions.net/companies/charles-river-laboratories/079ae978-a3c8-4c11-a1dc-3f036f3f6df0)
- [Fermion Oy](https://www.globalkeysolutions.net/companies/fermion-oy/8f4a5a6d-60c9-4ee0-a73f-d9107516d746)
- [GlaxoSmithKline Vaccines S.r.l.](https://www.globalkeysolutions.net/companies/glaxosmithkline-vaccines-srl/cddb07b7-c8a6-4dbd-a92c-c6ebeeb7e009)
- [AIRIS PHARMA PRIVATE LIMITED](https://www.globalkeysolutions.net/companies/airis-pharma-private-limited/fcbdc54b-e886-4781-a723-bf4bcf9c537d)

## Related Officers

- [Investigator ](https://www.globalkeysolutions.net/people/timothy-t-kapsala/b95b4741-063b-4bca-b6e0-f4889ae66196)
- [company_representative](https://www.globalkeysolutions.net/people/marcel-oerlemans/3192d3ea-3668-4d42-a11f-cf8555eefb92)
- [Investigator](https://www.globalkeysolutions.net/people/kellia-n-hicks/44104c4a-70c1-47fc-9a77-c09c41bacc2b)
- [Director, Team Biologics Staff](https://www.globalkeysolutions.net/people/helen-b-ricalde/455f022e-4d32-453e-acc7-e84a53ce730c)